These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 11075771

  • 1. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan.
    Khalil EA, El Hassan AM, Zijlstra EE, Mukhtar MM, Ghalib HW, Musa B, Ibrahim ME, Kamil AA, Elsheikh M, Babiker A, Modabber F.
    Lancet; 2000 Nov 04; 356(9241):1565-9. PubMed ID: 11075771
    [Abstract] [Full Text] [Related]

  • 2. Safety and immunogenicity of a candidate vaccine for visceral leishmaniasis (Alum-precipitated autoclaved Leishmania major + BCG) in children: an extended phase II study.
    Khalil EA, Musa AM, Modabber F, El-Hassan AM.
    Ann Trop Paediatr; 2006 Dec 04; 26(4):357-61. PubMed ID: 17132302
    [Abstract] [Full Text] [Related]

  • 3. Safety and immunogenicity of an autoclaved Leishmania major vaccine.
    Khalil EA, Elhassan AM, Zijlstra EE, Osman OF, Eljack IA, Ibrahim ME, Mukhtar MM, Ghalib HW, Modabbers F.
    East Afr Med J; 2000 Sep 04; 77(9):468-70. PubMed ID: 12862135
    [Abstract] [Full Text] [Related]

  • 4. Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.
    Sharifi I, FeKri AR, Aflatonian MR, Khamesipour A, Nadim A, Mousavi MR, Momeni AZ, Dowlati Y, Godal T, Zicker F, Smith PG, Modabber F.
    Lancet; 1998 May 23; 351(9115):1540-3. PubMed ID: 10326536
    [Abstract] [Full Text] [Related]

  • 5. Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers.
    Kamil AA, Khalil EA, Musa AM, Modabber F, Mukhtar MM, Ibrahim ME, Zijlstra EE, Sacks D, Smith PG, Zicker F, El-Hassan AM.
    Trans R Soc Trop Med Hyg; 2003 May 23; 97(3):365-8. PubMed ID: 15228261
    [Abstract] [Full Text] [Related]

  • 6. Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment.
    Musa AM, Khalil EA, Mahgoub FA, Elgawi SH, Modabber F, Elkadaru AE, Aboud MH, Noazin S, Ghalib HW, El-Hassan AM, Leishmaniasis Research Group/Sudan.
    Trans R Soc Trop Med Hyg; 2008 Jan 23; 102(1):58-63. PubMed ID: 17963805
    [Abstract] [Full Text] [Related]

  • 7. A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran.
    Momeni AZ, Jalayer T, Emamjomeh M, Khamesipour A, Zicker F, Ghassemi RL, Dowlati Y, Sharifi I, Aminjavaheri M, Shafiei A, Alimohammadian MH, Hashemi-Fesharki R, Nasseri K, Godal T, Smith PG, Modabber F.
    Vaccine; 1999 Feb 05; 17(5):466-72. PubMed ID: 10073725
    [Abstract] [Full Text] [Related]

  • 8. The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis.
    Alimohammadian MH, Khamesipour A, Darabi H, Firooz A, Malekzadeh S, Bahonar A, Dowlati Y, Modabber F.
    Vaccine; 2002 Dec 13; 21(3-4):174-80. PubMed ID: 12450691
    [Abstract] [Full Text] [Related]

  • 9. Immunogenicity and safety of autoclaved Leishmania major plus BCG vaccine in healthy Sudanese volunteers.
    Satti IN, Osman HY, Daifalla NS, Younis SA, Khalil EA, Zijlstra EE, El Hassan AM, Ghalib HW.
    Vaccine; 2001 Feb 28; 19(15-16):2100-6. PubMed ID: 11228382
    [Abstract] [Full Text] [Related]

  • 10. Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG.
    Mahmoodi M, Khamesipour A, Dowlati Y, Rafati S, Momeni AZ, Emamjomeh M, Hejazi H, Modabber F.
    Clin Exp Immunol; 2003 Nov 28; 134(2):303-8. PubMed ID: 14616791
    [Abstract] [Full Text] [Related]

  • 11. Dichotomy of protective cellular immune responses to human visceral leishmaniasis.
    Khalil EA, Ayed NB, Musa AM, Ibrahim ME, Mukhtar MM, Zijlstra EE, Elhassan IM, Smith PG, Kieny PM, Ghalib HW, Zicker F, Modabber F, Elhassan AM.
    Clin Exp Immunol; 2005 May 28; 140(2):349-53. PubMed ID: 15807861
    [Abstract] [Full Text] [Related]

  • 12. Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran.
    Mohebali M, Khamesipour A, Mobedi I, Zarei Z, Hashemi-Fesharki R.
    Vaccine; 2004 Sep 28; 22(29-30):4097-100. PubMed ID: 15364462
    [Abstract] [Full Text] [Related]

  • 13. Prophylactic potential of autoclaved Leishmania donovani with BCG against experimental visceral leishmaniasis.
    Srivastava JK, Misra A, Sharma P, Srivastava B, Naik S, Dube A.
    Parasitology; 2003 Aug 28; 127(Pt 2):107-14. PubMed ID: 12954011
    [Abstract] [Full Text] [Related]

  • 14. Vaccination of langur monkeys (Presbytis entellus) against Leishmania donovani with autoclaved L. major plus BCG.
    Dube A, Sharma P, Srivastava JK, Misra A, Naik S, Katiyar JC.
    Parasitology; 1998 Mar 28; 116 ( Pt 3)():219-21. PubMed ID: 9550214
    [Abstract] [Full Text] [Related]

  • 15. Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG.
    Misra A, Dube A, Srivastava B, Sharma P, Srivastava JK, Katiyar JC, Naik S.
    Vaccine; 2001 May 14; 19(25-26):3485-92. PubMed ID: 11348715
    [Abstract] [Full Text] [Related]

  • 16. Double-Blind Randomized Efficacy Field Trial of Alum Precipitated Autoclaved Leishmania major (Alum-ALM) Vaccine Mixed With BCG Plus Imiquimod Vs. Placebo Control Group.
    Barati M, Mohebali M, Alimohammadian MH, Khmesipour A, Keshavarz H, Akhoundi B, Zarei Z.
    Iran J Parasitol; 2015 May 14; 10(3):351-9. PubMed ID: 26622290
    [Abstract] [Full Text] [Related]

  • 17. Leishmaniasis in Sudan. Visceral leishmaniasis.
    Zijlstra EE, el-Hassan AM.
    Trans R Soc Trop Med Hyg; 2001 Apr 14; 95 Suppl 1():S27-58. PubMed ID: 11370250
    [Abstract] [Full Text] [Related]

  • 18. Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis.
    Zijlstra EE, el-Hassan AM, Ismael A, Ghalib HW.
    Am J Trop Med Hyg; 1994 Dec 14; 51(6):826-36. PubMed ID: 7810819
    [Abstract] [Full Text] [Related]

  • 19. A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH.
    Osman M, Mistry A, Keding A, Gabe R, Cook E, Forrester S, Wiggins R, Di Marco S, Colloca S, Siani L, Cortese R, Smith DF, Aebischer T, Kaye PM, Lacey CJ.
    PLoS Negl Trop Dis; 2017 May 14; 11(5):e0005527. PubMed ID: 28498840
    [Abstract] [Full Text] [Related]

  • 20. Immune response in healthy volunteers vaccinated with killed leishmanial promastigotes plus BCG. I: Skin-test reactivity, T-cell proliferation and interferon-gamma production.
    Castés M, Blackwell J, Trujillo D, Formica S, Cabrera M, Zorrilla G, Rodas A, Castellanos PL, Convit J.
    Vaccine; 1994 Aug 14; 12(11):1041-51. PubMed ID: 7975845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.